Determinação da histamina no coração de ratos exercitados

Authors

  • Marí­lia Mantovani Sampaio Barros UNICAMP

DOI:

https://doi.org/10.33233/fb.v1i2.616

Abstract

Este trabalho comparou os ní­veis de histamina (HA) no coração de ratos submetidos aos exercí­cios fí­sicos agudo e prolongado de natação com os ní­veis de HA no coração de ratos sedentários (controles). A eficácia do treinamento foi confirmada pela histologia e a determinação dos ní­veis de HA foi realizada pelo método fluorimétrico. A respeito do exercí­cio agudo, houve diminuição do ní­vel de HA no coração de ratos sedentários 1,43 ± 0,3164 mg/g (N = 10) em comparação com o respectivo controle 2,15 ± 0,3505 mg/g (N = 08). Houve também diminuição dos ní­veis de HA no coração de animais treinados em repouso, 1,42 ± 0,6130 mg/g (N = 07), em comparação com o grupo controle 2,15 ± 0,3505 mg/g (N = 08). O critério de significância estatí­stica foi p £ 0,05. Estes resultados sugerem que a HA pode participar da homeostasia microcirculatória de corações de ratos sedentários durante o exercí­cio agudo de natação e de ratos treinados em repouso.

Palavras-chave: coração, natação, histamina.

Author Biography

Marí­lia Mantovani Sampaio Barros, UNICAMP

Departamento de Fisiologia e Biofí­sica do Instituto de Biologia da Universidade Estadual de Campinas, SP

References

Henrichsen H, Halabi A, Kirch W. Clinical aspects of cardiovascular effects of H2-receptor antagonists. J Clin Pharmacol 1995;35:107-16.

Kostic MM, Jakovljevic VLJ. Role of histamine in the regulation of coronary circulation. Physiol Res 1996;45:297-303.

Dubowitz V, Brooke MH. Muscle biopsy: a modern approach. London: Saunders, 1973. p. 475.

Sampaio-Barros MM, Azevedo JRMA, Kokubun E et al. Dosagem histamínica muscular de ratos exercitados. Rev Paul Educ Fís 1995;9(1):3-9.

Shore PA, Burkhalter A, Cohn VH. A method for the fluorimetric assay of histamine in tissues. J Pharmacol Exp Ther 1959;127:182-6.

Roscoe JT. Fundamental research statistics for the behavioral sciences. 2 ed, Holt: Rinehart and Winston, 1975. p. 217-223; 230-7.

Graham P, Kahlson G, Rosengren E. Histamine formation in physical exercise, anoxia and under the influence of adrenaline and related substances. J Physiol 1964;172:174-88.

Harpur RP. The rat as a model for physical fitness studies. Comp Biochem Physiol 1980;66A:553-74.

Noble MIM. Enhancement of mechanical performance of striated muscle by strech during contraction. Exp Physiol 1992;77:539-52.

Babe Jr. KS, Serafin WE. Histamine, bradykinin, and their antagonists . In: Hardman JG, Goodman GA, Limbird LE. The pharmacological bases of therapeutics. 9th ed, New York: Mc Graw-Hill, 1996. p. 581-600.

Hatta E, Yasuda K, Levi R. Activation of histamine H3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J Pharmacol Exp Ther 1997;283(2):494-500.

Feldberg W, Talesnik J. Reduction of tissue histamine by compound 48/80. J Physiol 1953;120:550-68.

Bigard AX, Brunet, A., Guezennec, C. Y. et al. Effects of chronic hypoxia and endurance training on muscle capillarity. Pflügers Arch 1991;419:225-32.

Langeler EG, Snelting-Havinga I, Van Hinsbergh VW. Passage of low density lipoproteins through monolayers of human arterial endothelial cells. Effects of vasoactive substances in an in vitro model. Arteriosclerosis 1989;9:550-559.

Liao W, Rudling M, Angelin B. Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat. Endocrinology 1997;138(5):1863-70.

Parikh V, Singh M. Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 1997;30(2):149-56.

Malinowska B, Godlewski G, Schlicker E. Histamine H-3 receptors – general characterization and their function in the cardiovascular system. J Physiol Pharmacol 1998;49(2):191-211.

Pang XZ, Alexacos N, Letourneau R et al. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process. J Pharmacol Exp Ther 1998;287(1):307-14.

Published

2016-12-10

Issue

Section

Original articles